Main > > >DRUG DEPENDENCE. *

---

Alcohol Dependence. Breath Analysis & Monitoring.
USA Approval Date: 2016. 07.14.
(*) Company; Patents & Web-Site Avai-
lable on Request.
UpDate: 2019. 01.11.




Opioid Dependence. TREAT.: Buprenorphine ER Once Monthly
Injectable Formulation.
USA Approval Date: 2017. 11.30.
(*) Company; Patents; TradeMark & Web-
Site Available on Request.
UpDate: 2018. 03.18.




Opioid Dependence. TREAT.: Buprenorphine+Naloxone SubLingual Film (CIII). Brand (UK>I)
(*) Company; Patents; TradeMark & Web-
Site Available on Request.
USA Approval Date: 2010. 08.30.
UpDate: 2018. 03.18.




Opioid Dependence. TREAT.: Buprenorphine+Naloxone SubLingual Film. (CIII). Generics. (UK>M)
USA Approval Date: 2018. 06.14.
(*) Company: Mylan
UpDate: 2018. 12.02.




Opioid Dependence. TREAT.: Buprenorphine+Naloxone SubLingual Tab.
EU Approval Date : 2017. 11.
USA Approval Date: 2013. 07.03.
(*) Companies; Patents; TradeMark &
Web-Site Available on Request.
UpDate: 2018. 12.02.


>DRUG DEPENDENCE. *'s products
This section has no products